SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-027083
Filing Date
2024-07-12
Accepted
2024-07-12 16:00:16
Documents
14
Period of Report
2024-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 from8-k.htm   iXBRL 8-K 43910
2 ex10-1.htm EX-10.1 48799
  Complete submission text file 0001493152-24-027083.txt   272962

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE orgs-20240712.xsd EX-101.SCH 3018
4 XBRL LABEL FILE orgs-20240712_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE orgs-20240712_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT from8-k_htm.xml XML 3535
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 241114445
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)